首页> 外文期刊>The journal of clinical endocrinology and metabolism >Update in TSH Receptor Agonists and Antagonists
【24h】

Update in TSH Receptor Agonists and Antagonists

机译:TSH受体激动剂和拮抗剂的更新

获取原文
       

摘要

The physiological role of the TSH receptor (TSHR) as a major regulator of thyroid function is well understood, but TSHRs are also expressed in multiple normal extrathyroidal tissues, and the physiological roles of TSHRs in these tissues are unclear. Moreover, TSHRs play a major role in several pathological conditions including hyperthyroidism, hypothyroidism, and thyroid tumors. Small molecule, “drug-like” TSHR agonists, neutral antagonists, and inverse agonists may be useful as probes of TSHR function in extrathyroidal tissues and as leads to develop drugs for several diseases of the thyroid. In this Update, we review the most recent findings regarding the development and use of these small molecule TSHR ligands.
机译:TSH受体(TSHR)作为甲状腺功能的主要调节剂的生理作用已广为人知,但TSHRs在多种正常的甲状腺外组织中也有表达,尚不清楚TSHRs在这些组织中的生理作用。此外,TSHRs在几种病理状况中起主要作用,包括甲状腺功能亢进,甲状腺功能减退和甲状腺肿瘤。小分子,“药物样” TSHR激动剂,中性拮抗剂和反向激动剂可能可用作甲状腺外组织中TSHR功能的探针,并导致开发治疗多种甲状腺疾病的药物。在此更新中,我们回顾了有关这些小分子TSHR配体的开发和使用的最新发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号